Ken Davis, CEO of Mount Sinai Health System
Question: Ken, most everyone knows you as CEO of Mount Sinai—the renowned $8 billion, 38,000-employee system in New York City. But not everyone is aware of your clinical background, particularly your pioneering research in Alzheimer's and schizophrenia. You authored or co-authored 575 scientific studies, and were chair of psychiatry at Mount Sinai for 15 years, prior to becoming CEO in 2003. As you reflect back on your earlier, pre-CEO experiences, any particular moments stand out?